Tortoise Pipeline & Energy Fund (TTP) 21.03

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tortoise Pipeline & Energy Fund (TTP) 21.03 $TTP

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Aug. 31, 2016
BusinessWire - Thu Sep 01, 4:34PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Aug. 31, 2016, the company's unaudited total assets were approximately $284.7 million and its unaudited net asset value was $218.4 million, or $21.80 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Section 19(a) Notice
BusinessWire - Wed Aug 31, 4:00PM CDT
This notice provides stockholders of Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) with information regarding the distribution paid on Aug. 31, 2016 and cumulative distributions paid fiscal year-to-date.
TTP: 21.03 (+0.34)

Tortoise Capital Advisors Announces Distribution Amounts and Dates for Closed-End Funds (TYG, NTG, TTP, NDP, TPZ)
BusinessWire - Mon Aug 08, 3:30PM CDT
The closed-end funds managed by Tortoise Capital Advisors declared the following distributions today:
TTP: 21.03 (+0.34), TPZ: 21.78 (+0.11), NDP: 16.15 (+0.03), NTG: 20.26 (+0.26), TYG: 31.06 (+0.68)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of July 31, 2016
BusinessWire - Mon Aug 01, 5:13PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of July 31, 2016, the company's unaudited total assets were approximately $281.3 million and its unaudited net asset value was $215.2 million, or $21.48 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of May 31, 2016
BusinessWire - Wed Jun 01, 5:15PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of May 31, 2016, the company's unaudited total assets were approximately $269.4 million and its unaudited net asset value was $202.6 million, or $20.23 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of April 30, 2016
BusinessWire - Mon May 02, 4:47PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of April 30, 2016, the company's unaudited total assets were approximately $272.5 million and its unaudited net asset value was $197.5 million, or $19.72 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of March 31, 2016
BusinessWire - Fri Apr 01, 5:17PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of March 31, 2016, the company's unaudited total assets were approximately $235.4 million and its unaudited net asset value was $169.5 million, or $16.92 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Announces Upcoming Distribution
BusinessWire - Tue Feb 09, 3:56PM CST
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today declared a first quarter 2016 distribution of $0.4075 per share. The distribution is payable on Feb. 29, 2016 to stockholders of record on Feb. 22, 2016. The ex-dividend date is Feb. 18, 2016.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Jan. 31, 2016
BusinessWire - Mon Feb 01, 5:27PM CST
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Jan. 31, 2016, the company's unaudited total assets were approximately $214.2 million and its unaudited net asset value was $148.6 million, or $14.83 per share.
TTP: 21.03 (+0.34)

Tortoise Capital Advisors Announces 2015 Closed-End Fund Tax Characterization of Distributions and Release of Combined Annual Report
BusinessWire - Wed Jan 20, 5:42PM CST
Tortoise Capital Advisors today announced the tax characterization of 2015 distributions paid to common stockholders of:
TTP: 21.03 (+0.34), TPZ: 21.78 (+0.11), NDP: 16.15 (+0.03), NTG: 20.26 (+0.26), TYG: 31.06 (+0.68)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Dec. 31, 2015
BusinessWire - Mon Jan 04, 5:00PM CST
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Dec. 31, 2015, the company's unaudited total assets were approximately $241.5 million and its unaudited net asset value was $166.7 million, or $16.64 per share.
TTP: 21.03 (+0.34)

Tortoise Capital Advisors' Weekly "QuickTake" Audio Podcast Series Provides Energy Sector and Fund Updates
BusinessWire - Mon Dec 21, 8:20AM CST
Tortoise Capital Advisors recently launched a weekly "QuickTake" audio podcast series to provide timely updates on the energy sector. The podcasts are available on its website at www.tortoiseadvisors.com.
TTP: 21.03 (+0.34), TPZ: 21.78 (+0.11), NDP: 16.15 (+0.03), NTG: 20.26 (+0.26), TYG: 31.06 (+0.68)

Tortoise Capital Advisors Releases Updated Top Ten Holdings
BusinessWire - Wed Dec 09, 7:58AM CST
Tortoise Capital Advisors today announced that it, in light of recent market volatility, has released updated top ten holdings for its funds as of Dec. 04, 2015 on its website at www.tortoiseadvisors.com
TTP: 21.03 (+0.34), TPZ: 21.78 (+0.11), NDP: 16.15 (+0.03), NTG: 20.26 (+0.26), TYG: 31.06 (+0.68)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Nov. 30, 2015
BusinessWire - Tue Dec 01, 4:40PM CST
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Nov. 30, 2015, the company's unaudited total assets were approximately $286.0 million and its unaudited net asset value was $197.4 million, or $19.71 per share.
TTP: 21.03 (+0.34)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Oct. 31, 2015
BusinessWire - Mon Nov 02, 5:51PM CST
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Oct. 31, 2015, the company's unaudited total assets were approximately $320.7 million and its unaudited net asset value was $228.5 million, or $22.81 per share.
TTP: 21.03 (+0.34)

Tortoise Capital Advisors, L.L.C. Announces Release of Third Quarter 2015 Reports for Closed-End Funds (TYG, NTG, TTP, NDP, TPZ)
BusinessWire - Fri Oct 23, 3:59PM CDT
Tortoise Capital Advisors, L.L.C., the adviser of TYG, NTG, TTP, NDP and TPZ, announced today the release of third quarter 2015 stockholders' reports for each of these funds.
TTP: 21.03 (+0.34), TPZ: 21.78 (+0.11), NDP: 16.15 (+0.03), NTG: 20.26 (+0.26), TYG: 31.06 (+0.68)

Tortoise Pipeline & Energy Fund, Inc. Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Update as of Sept. 30, 2015
BusinessWire - Thu Oct 01, 7:00PM CDT
Tortoise Pipeline & Energy Fund, Inc. (NYSE: TTP) today announced that as of Sept. 30, 2015, the company's unaudited total assets were approximately $302.7 million and its unaudited net asset value was $204.3 million, or $20.39 per share.
TTP: 21.03 (+0.34)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading